Lifespan Cancer Institute - Providence /ID# 266550

Providence, Rhode Island 02903

1 studies enrolling now · 1 studies all time

What they study most

Chronic Lymphocytic Leukemia

Studies at this site

• A Study to Evaluate the Risk of Tumor Lysis Syndrome (TLS) in Adult Participants Receiving Oral Venetoclax in Combination With Intravenously Infused Obinutuzumab or Oral Acalabrutinib for Previously Untreated Chronic Lymphocytic Leukemia (CLL) — Recruiting now